ENvue Medical receives Nasdaq delisting notice for bid price non-compliance

ENvue Medical, Inc.

Closing bid price below $1.00 for 30 consecutive business days (May 26–July 8, 2026).
Ineligible for 180-day cure period due to reverse stock split (1-for-10) on Aug 12, 2025.
Company will request a hearing before Nasdaq Panel to appeal the determination.
No assurance that continued listing will be granted or compliance regained.

Featured in Daily 8-K Digest

Selected #2 for 2026-07-10. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.